Crossref
Ischemia Modified Albumin as a Novel Biochemical Indicator in Peripheral Artery Patients
Journal of Clinical and Experimental Investigations · 2021
DOI: 10.29333/jcei/10960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Experimental Investigations, 2021. Verfasst von Hasan Basri Savas und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Savas, H. B., & Etli, M. (2021). Ischemia Modified Albumin as a Novel Biochemical Indicator in Peripheral Artery Patients. Journal of Clinical and Experimental Investigations. https://doi.org/10.29333/jcei/10960
Vancouver
Savas HB, Etli M. Ischemia Modified Albumin as a Novel Biochemical Indicator in Peripheral Artery Patients. Journal of Clinical and Experimental Investigations. 2021. doi:10.29333/jcei/10960
BibTeX
@article{Savas2021,
author = {Savas, Hasan Basri and Etli, Mustafa},
title = {Ischemia Modified Albumin as a Novel Biochemical Indicator in Peripheral Artery Patients},
journal = {Journal of Clinical and Experimental Investigations},
year = {2021},
doi = {10.29333/jcei/10960}
}
EUVIMED